Spotlight on Sweden
Sweden saw strong levels of dealflow in Q3, but limited access for cross-border buyers and scarcer debt financing continue to pose challenges, says Clearwater International’s Managing Partner Tomas Almgren.
Read moreWe work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Luc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 60
deals advised upon
in the last 5 years
€9.2bn
in deal value
over the last 5 years
Over 45%
deals involving PE
in the last 5 years
Sweden saw strong levels of dealflow in Q3, but limited access for cross-border buyers and scarcer debt financing continue to pose challenges, says Clearwater International’s Managing Partner Tomas Almgren.
Read moreThis report identifies key themes driving European Private Equity (PE) deals’ EV/EBITDA multiples on a quarterly basis. The objective is to assist PE investors in understanding drivers behind value trends across regions and sectors, leading to good investment opportunities.
Read moreIn-depth analysis of the acquisition multiples paid for European private equity transactions.
Read more